» Articles » PMID: 6473094

Binding of Heparin and Low Molecular Weight Heparin Fragments to Human Vascular Endothelial Cells in Culture

Overview
Specialty Hematology
Date 1984 Jan 1
PMID 6473094
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The interaction of standard heparin and some low molecular weight heparin fragments (CY 222, mw 1,500-8,000 daltons) with human vascular endothelium in culture was studied using both 125I and 3H labeled ligands. A specific and saturable binding was shown for both labeled standard heparins. Two populations of binding sites for 3H-standard heparin could be distinguished: one of high affinity (KD = 0.12 microM), and another of lower affinity (KD = 1.37 microM). Total binding capacity was in the order of 10(7) molecules per cell. The same high level of affinity was calculated for unlabeled compounds from competition experiments with 125I-standard heparin. No other glycosaminoglycans, except a highly sulfated heparan (fraction IIA) could compete for heparin binding sites. A specific binding was also shown for 125I-CY 222. The affinity of unlabeled CY 222 was approximately ten times lower than that of unfractionated heparin. However, CY 222 could compete for approximatively 30% of standard heparin binding. Binding was not completely reversible. Even in the presence of a large excess of unlabeled compounds, a fraction of 25% of radioactive heparins remained bound to the endothelium. This fraction was three times lower if incubation was carried out at +4 degrees C, suggesting a possible incorporation of heparin into the endothelial cells.

Citing Articles

Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?.

Leentjens J, Peters M, Esselink A, Smulders Y, Kramers C Br J Clin Pharmacol. 2017; 83(11):2356-2366.

PMID: 28593681 PMC: 5651323. DOI: 10.1111/bcp.13340.


Hydrogel surfaces to promote attachment and spreading of endothelial progenitor cells.

Camci-Unal G, Nichol J, Bae H, Tekin H, Bischoff J, Khademhosseini A J Tissue Eng Regen Med. 2012; 7(5):337-47.

PMID: 22223475 PMC: 3326228. DOI: 10.1002/term.517.


Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations.

Dryjski M, SCHNEIDER D, Mojaverian P, Kuo B, Bjornsson T Br J Clin Pharmacol. 1989; 28(2):188-92.

PMID: 2550047 PMC: 1379904. DOI: 10.1111/j.1365-2125.1989.tb05415.x.


Endothelial binding sites for heparin. Specificity and role in heparin neutralization.

Barzu T, Van Rijn J, Petitou M, Molho P, Tobelem G, Caen J Biochem J. 1986; 238(3):847-54.

PMID: 2432885 PMC: 1147213. DOI: 10.1042/bj2380847.


Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers.

de Boer A, Stiekema J, Danhof M, Van Dinther T, Boeijinga J, Cohen A Antimicrob Agents Chemother. 1991; 35(10):2110-5.

PMID: 1759835 PMC: 245335. DOI: 10.1128/AAC.35.10.2110.